Interventional Oncology Products

SUNY Downstate Health Sciences University is procuring an agreement for interventional oncology products through May 31, 2027, utilizing Premier Consortia Contract PP-CA-701. This procurement is conducted under New York State Finance Law section 163(3)(vi), which allows for the use of a consortium in lieu of a centralized contract when justified by price. The scope of work involves the acquisition of medical consumables, specifically various MRI-conditional and non-radiolucent embolization coils including Retracta, MREye, MREye Flipper, Nester, and Tornado models, with specifications ranging from 3mm to 20mm in diameter and constructed from materials such as Inconel, synthetic fiber, and platinum. The contract term is not to exceed three years, with a performance end date of May 31, 2027, and the place of performance located at 450 Clarkson Avenue in Brooklyn, New York. While the procurement is based on the Premier Consortia contract, vendors offering equivalent and compatible consumables may contact Purchase Associate Carlos Villegas to discuss the procurement, provided they can demonstrate that their products are interchangeable with existing equipment and accessories. The solicitation, identified by number 2140539 and contract number 27124096, established a response deadline of November 27, 2026.